Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Opsens Inc T.OPS

Alternate Symbol(s):  OPSSF

OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. The Company supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

Perte de 0,03

Comment peut-t'on faire une perte avec des ventes record. Difficile a comprendre cette cpmpagnie  rate and reply

marketwatch.com headline

OpSens 1Q Revenue Jumps 26%, Beating Expectations  rate and reply

Q1

TAVR sales of $0.4 million , the first sign of how  SavvyWire is selling . "We are still in the early days of the launch cycle but to this point, we have achieved or exceeded nearly every...read more

New Press Release - OPSENS ANNOUNCES RECORD FIRST QUARTER FISCAL 2023 FINANCIAL RESULTS

Conference call on the results today at 11:00 a.m. ETQUEBEC CITY, Jan. 12, 2023 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today reported...read article.

RE:Q1 Financial Report

I agree on some of your points but using the parking lot occupancy index on january 4 th is not revelent.Any employee who has a kid is on vacation because their kids are not in school yet. GL  rate and reply

New Press Release - OPSENS TO HOST FIRST QUARTER FISCAL YEAR 2023 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY JANUARY 12, 2023

Conference call to be conducted at 11:00 am ETQUEBEC CITY, Jan. 5, 2023 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, will report financial...read article.

RE:Great interest...

Sorry but I forgot to add: Be ready to loose yout bet or win the ''jack pot'' with a potential take over proposal in 18 months ! This is the way to look at OPS,a 300 employees...read more

Great interest...

Pretty good interest in this stellar company 35 reads  in 10 minutes Just keep track on this ''GEM''  rate and reply

Quite surprising ...1

Just 84 views in a couple of hours  from anxious  share holders looking for the big announcement ! Great interest in this potential outstanding Company  Of course... not acting ...read more

Q1 Financial Report

Should announced Q1 FR in 48 hours.. I'm not expecting Big numbers but hope to see a better results than the Q1 2022 ''Highlights for the quarter:   Consolidated sales of $8.1...read more

RE:Good day for OPS

This stock is being played. Walked down early in the day on sells of 100 or 200 shares, then with 10 minutes to go before close, nearly 34K shares come in at $1.90 and once again, we're back to...read more

Good day for OPS

Nice volume in Canada and US. Price in the right direction. Q1 results next week. Let's hope for great news regarding Savvywire adoption and sales figures. GLTA  rate and reply

Small Cap Bounce?

In times of great pessimism there is opportunity. But also, there is almost always a small cap bounce in January. This occurs once tax-loss selling is over, because small cap stocks are less liquid...read more

A takeover bid by big tech cie is welcome .

eom.  rate and reply

RE:RE:RE:RE:RE:Raymond James

Patience is still necessary here . I also was disappointed at the $1.90 financing . Best wishes for the holiday season and here's to a successful 2023 .  rate and reply

RE:Necessary to have funds to develop...

FromSarugaser “We continue to have strong long-term conviction that SavvyWire’s unique 3-in-1 TAVR capability represents compelling commercial potential that could drive OPS’ top-line revenue to $100...read more

RE:RE:RE:RE:Raymond James

Also a shelf prospectus filed, in case more money is needed. which gives potential access to more capital.  rate and reply

RE:OPSSF

And volume in the US has increased lately. Some people in the States must see the huge potential of the Savvywire. Especially the interventionist cardios who have tried it.  rate and reply

OPSSF

Meanwhile in the US Opsens is up 0.03 cents or 2 1/4 %  rate and reply